CLINICAL_TRIALS
trial_result
· 2018-03-09
Clinical Trial Update: Phlebotomy Study of Testosterone Undecanoate [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating testosterone undecanoate for hypogonadism has completed; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clarus Therapeutics, Inc. | Conditions: Hypogonadism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-03-09